PHA-Exchange> Abbott to cut AIDS drug price in 40 poor countries
claudio at hcmc.netnam.vn
claudio at hcmc.netnam.vn
Wed Apr 11 16:22:48 PDT 2007
- from Vern Weitzel <vern at coombs.anu.edu.au> -----
http://thestar.com.my/news/story.asp?file=/2007/4/11/worldupdates/2007-04-
11T024421Z_01_NOOTR_RTRJONC_0_-293754-1&sec=worldupdates
Abbott to cut AIDS drug price in 40 poor countries
By Kim Dixon
CHICAGO (Reuters) - Abbott Laboratories Inc., widely criticized for aggressive
pricing of its AIDS
medicines in developing countries, said on Tuesday it would slash the price of
a key AIDS drug by
more than half in more than 40 poor countries.
Abbott said it would offer its drug Kaletra at a price of $1,000 per patient
per year -- a price
lower than generic versions -- to governments of more than 40 countries with
low and low-middle
income, as defined by World Bank criteria.
The move is an apparent attempt to cool tensions with its critics, amid a spat
with the government
of Thailand over AIDS drug pricing.
The company has had a worse-than-average reputation with AIDS patient groups,
notably after a 400
percent price hike it set a few years ago for another AIDS drug. Advocates
were mixed on the
significance of the Kaletra announcement.
------------------------------------------------------------------
This mail sent through Netnam-HCMC ISP: http://www.hcmc.netnam.vn/
More information about the PHM-Exchange
mailing list